Assessment of Endothelial Dysfunction: The Role of Symmetrical Dimethylarginine and Proinflammatory Markers in Chronic Kidney Disease and Renal Transplant Recipients

Table 2

OR for impaired FMD in CKD and RT patients.

	Unadjusted OR	OR adjusted for GFR
SDMA	5.25 (1.894–14.550); 𝑃=0.001	3.342 (1.030–10.847); 𝑃=0.045
hs-CRP	4.24 (1.677–10.746); 𝑃=0.002	3.738 (1.450–9.638); 𝑃=0.006
IL-6	2.10 (0.841–5.262); 𝑃=0.112	/
SAA	2.381 (1.000–5.665); 𝑃=0.051	/
O2^•−	0.844 (0.313–2.280); 𝑃=0.739	/

OR: odds ratio; CI: confidence interval. SDMA, hs-CRP, IL-6, SAA, and O₂^•−: categorical variables.